Effect of Oral Azithromycin vs Placebo on COVID-19 Symptoms in Outpatients With SARS-CoV-2 Infection: A Randomized Clinical Trial

IMPORTANCE: Azithromycin has been hypothesized to have activity against SARS-CoV-2. OBJECTIVE: To determine whether oral azithromycin in outpatients with SARS-CoV-2 infection leads to absence of self-reported COVID-19 symptoms at day 14. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial o...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA
Main Authors: Oldenburg, Catherine E., Pinsky, Benjamin A., Brogdon, Jessica, Chen, Cindi, Ruder, Kevin, Zhong, Lina, Nyatigo, Fanice, Cook, Catherine A., Hinterwirth, Armin, Lebas, Elodie, Redd, Travis, Porco, Travis C., Lietman, Thomas M., Arnold, Benjamin F., Doan, Thuy
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2021
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8285753/
https://ncbi.nlm.nih.gov/pubmed/34269813
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2021.11517
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados